Faes Farma, S.A. (FAE.MC)
EUR 3.47
(0.14%)
EUR 3.47
(0.14%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.30 EUR | 3.45% |
| 2022 | 0.29 EUR | 3.57% |
| 2021 | 0.28 EUR | 7.69% |
| 2020 | 0.26 EUR | 13.04% |
| 2019 | 0.23 EUR | 21.05% |
| 2018 | 0.19 EUR | 26.67% |
| 2017 | 0.15 EUR | 7.14% |
| 2016 | 0.14 EUR | 16.67% |
| 2015 | 0.12 EUR | 20.97% |
| 2014 | 0.10 EUR | 6.21% |
| 2013 | 0.09 EUR | 8.98% |
| 2012 | 0.09 EUR | 32.25% |
| 2011 | 0.06 EUR | -29.03% |
| 2010 | 0.09 EUR | -8.7% |
| 2009 | 0.10 EUR | -9.09% |
| 2008 | 0.11 EUR | -8.33% |
| 2007 | 0.12 EUR | -20.0% |
| 2006 | 0.15 EUR | 64.11% |
| 2005 | 0.09 EUR | -2.25% |
| 2004 | 0.09 EUR | 21.74% |
| 2003 | 0.08 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.09 EUR | -8.48% |
| 2024 Q1 | 0.10 EUR | -24.69% |
| 2023 FY | - EUR | 3.45% |
| 2023 Q3 | 0.07 EUR | -60.35% |
| 2023 Q4 | 0.13 EUR | 92.88% |
| 2023 Q1 | 0.09 EUR | -27.58% |
| 2023 Q2 | 0.17 EUR | 95.63% |
| 2022 Q2 | 0.09 EUR | 3.35% |
| 2022 Q3 | 0.07 EUR | -23.24% |
| 2022 Q4 | 0.12 EUR | 80.72% |
| 2022 Q1 | 0.08 EUR | 117.97% |
| 2022 FY | - EUR | 3.57% |
| 2021 Q2 | 0.09 EUR | 22.95% |
| 2021 FY | - EUR | 7.69% |
| 2021 Q4 | 0.04 EUR | -50.26% |
| 2021 Q3 | 0.08 EUR | -11.06% |
| 2021 Q1 | 0.07 EUR | 112.01% |
| 2020 FY | - EUR | 13.04% |
| 2020 Q1 | 0.07 EUR | 42.8% |
| 2020 Q2 | 0.09 EUR | 23.39% |
| 2020 Q3 | 0.06 EUR | -31.56% |
| 2020 Q4 | 0.03 EUR | -44.78% |
| 2019 Q3 | 0.05 EUR | -32.25% |
| 2019 Q2 | 0.07 EUR | 28.35% |
| 2019 FY | - EUR | 21.05% |
| 2019 Q1 | 0.06 EUR | 56.25% |
| 2019 Q4 | 0.05 EUR | 0.0% |
| 2018 Q2 | 0.06 EUR | 13.75% |
| 2018 Q4 | 0.04 EUR | -19.47% |
| 2018 FY | - EUR | 26.67% |
| 2018 Q1 | 0.05 EUR | 51.49% |
| 2018 Q3 | 0.05 EUR | -21.07% |
| 2017 Q3 | 0.04 EUR | -4.56% |
| 2017 FY | - EUR | 7.14% |
| 2017 Q1 | 0.04 EUR | 37.98% |
| 2017 Q4 | 0.03 EUR | -23.64% |
| 2017 Q2 | 0.05 EUR | 29.49% |
| 2016 FY | - EUR | 16.67% |
| 2016 Q4 | 0.03 EUR | -40.83% |
| 2016 Q3 | 0.04 EUR | 3.32% |
| 2016 Q2 | 0.04 EUR | 32.29% |
| 2016 Q1 | 0.03 EUR | 53.37% |
| 2015 Q2 | 0.04 EUR | 26.95% |
| 2015 Q3 | 0.04 EUR | 6.98% |
| 2015 Q4 | 0.02 EUR | -45.69% |
| 2015 FY | - EUR | 20.97% |
| 2015 Q1 | 0.03 EUR | 112.03% |
| 2014 Q3 | 0.03 EUR | -4.26% |
| 2014 Q4 | 0.01 EUR | -60.53% |
| 2014 Q2 | 0.04 EUR | 39.13% |
| 2014 FY | - EUR | 6.21% |
| 2014 Q1 | 0.03 EUR | 343.86% |
| 2013 Q2 | 0.02 EUR | -40.67% |
| 2013 Q3 | 0.04 EUR | 84.51% |
| 2013 Q4 | 0.01 EUR | -85.5% |
| 2013 FY | - EUR | 8.98% |
| 2013 Q1 | 0.04 EUR | 3888.89% |
| 2012 Q1 | 0.03 EUR | 1881.25% |
| 2012 Q3 | 0.05 EUR | 233.58% |
| 2012 FY | - EUR | 32.25% |
| 2012 Q4 | 0.00 EUR | -98.03% |
| 2012 Q2 | 0.01 EUR | -51.93% |
| 2011 Q1 | 0.04 EUR | 0.0% |
| 2011 Q4 | -0.00 EUR | -108.6% |
| 2011 Q3 | 0.02 EUR | 63.16% |
| 2011 FY | - EUR | -29.03% |
| 2011 Q2 | 0.01 EUR | -72.92% |
| 2010 Q1 | 0.04 EUR | 0.0% |
| 2010 FY | - EUR | -8.7% |
| 2010 Q2 | 0.02 EUR | -49.07% |
| 2009 FY | - EUR | -9.09% |
| 2008 FY | - EUR | -8.33% |
| 2007 FY | - EUR | -20.0% |
| 2006 FY | - EUR | 64.11% |
| 2005 FY | - EUR | -2.25% |
| 2004 FY | - EUR | 21.74% |
| 2003 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Almirall, S.A. | -0.20 EUR | 250.0% |
| Laboratorio Reig Jofre, S.A. | 0.12 EUR | -150.0% |